T1	PROC 1 21	Estudio aleatorizado
#1	AnnotatorNotes T1	C0206034; Clinical Trials, Randomized; Research Activity
T2	PROC 54 97	terapia estándar contra Helicobacter pylori
T3	CHEM 102 116	claritromicina
#2	AnnotatorNotes T3	C0055856; clarithromycin; Organic Chemical · Antibiotic
T4	CHEM 124 137	levofloxacina
#3	AnnotatorNotes T4	C0282386; levofloxacin; Organic Chemical · Antibiotic
T5	PROC 203 226	terapia triple estándar
#4	AnnotatorNotes T5	C0581065; Triple therapy helicobacter pylori; Therapeutic or Preventive Procedure
T6	DISO 237 260	infección por H. pylori
#5	AnnotatorNotes T6	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T7	PROC 302 309	terapia
#6	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	CHEM 321 334	levofloxacina
#7	AnnotatorNotes T8	C0282386; levofloxacin; Organic Chemical · Antibiotic
T9	CHEM 336 347	amoxicilina
#8	AnnotatorNotes T9	C0002645; amoxicillin; Organic Chemical · Antibiotic
T10	CHEM 353 386	inhibidor de la bomba de protones
#9	AnnotatorNotes T10	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T11	PROC 483 507	terapia de primera línea
#10	AnnotatorNotes T11	C1708063; First line treatment; Therapeutic or Preventive Procedure
T12	PROC 530 578	estudio aleatorizado, multicéntrico y controlado
#11	AnnotatorNotes T12	C0206035; Controlled Clinical Trials, Randomized; Research Activity + C1096776; Multicenter Study; Research Activity
T13	PROC 606 618	erradicación
#12	AnnotatorNotes T13	C3178994; Disease Eradication; Health Care Activity
T14	PROC 636 643	terapia
#13	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	CHEM 664 678	claritromicina
#14	AnnotatorNotes T15	C0055856; clarithromycin; Organic Chemical · Antibiotic
T16	CHEM 680 691	amoxicilina
#15	AnnotatorNotes T16	C0002645; amoxicillin; Organic Chemical · Antibiotic
T17	CHEM 694 703	omeprazol
#16	AnnotatorNotes T17	C0028978; omeprazole; Organic Chemical · Pharmacologic Substance
T18	CHEM 717 730	levofloxacina
#17	AnnotatorNotes T18	C0282386; levofloxacin; Organic Chemical · Antibiotic
T19	CHEM 732 743	amoxicilina
#18	AnnotatorNotes T19	C0002645; amoxicillin; Organic Chemical · Antibiotic
T20	CHEM 746 755	omeprazol
#19	AnnotatorNotes T20	C0028978; omeprazole; Organic Chemical · Pharmacologic Substance
T21	PROC 816 839	diagnóstico por biopsia
#20	AnnotatorNotes T21	C0005558; Biopsy; Diagnostic Procedure + C0011900; Diagnosis; Diagnostic Procedure
T22	PROC 894 914	regímenes de terapia
T23	PROC 928 944	terapia estándar
#21	AnnotatorNotes T23	C2936643; Standard of Care; Health Care Activity
T24	PROC 977 989	erradicación
#22	AnnotatorNotes T24	C3178994; Disease Eradication; Health Care Activity
T25	PROC 1010 1027	prueba de aliento
#23	AnnotatorNotes T25	C0006153; Breath Tests; Diagnostic Procedure
T26	DISO 1044 1060	efectos adversos
#24	AnnotatorNotes T26	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T27	PROC 1119 1151	análisis por intención de tratar
#25	AnnotatorNotes T27	C2718028; Intention to Treat Analysis; Research Activity
T28	PROC 1216 1225	protocolo
#26	AnnotatorNotes T28	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T29	PROC 1239 1251	erradicación
#27	AnnotatorNotes T29	C3178994; Disease Eradication; Health Care Activity
T30	PROC 1386 1397	tratamiento
#28	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	DISO 1450 1466	efectos adversos
#29	AnnotatorNotes T31	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T32	PROC 1507 1518	tratamiento
#30	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	PROC 1527 1543	terapia estándar
#31	AnnotatorNotes T33	C2936643; Standard of Care; Health Care Activity
T34	CHEM 1556 1569	levofloxacina
#32	AnnotatorNotes T34	C0282386; levofloxacin; Organic Chemical · Antibiotic
T35	DISO 1578 1601	infección por H. pylori
#33	AnnotatorNotes T35	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T36	PROC 1635 1661	erradicación del H. pylori
#34	AnnotatorNotes T36	C0559761; Helicobacter eradication therapy; Therapeutic or Preventive Procedure
T37	PROC 1678 1685	terapia
#35	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	CHEM 1696 1710	claritromicina
#36	AnnotatorNotes T38	C0055856; clarithromycin; Organic Chemical · Antibiotic
T39	PROC 431 438	régimen
#37	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	DISO 843 866	infección por H. pylori
#38	AnnotatorNotes T40	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T41	PROC 874 887	aleatorizados
#39	AnnotatorNotes T41	C0034656; Randomization; Research Activity
T42	LIVB 78 97	Helicobacter pylori
#40	AnnotatorNotes T42	C0079488; Helicobacter pylori; Bacterium
T43	Duration 142 149	10 días
T44	Spec_cue 445 453	sugerido
T45	LIVB 802 811	pacientes
#41	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Duration 919 926	10 días
T48	LIVB 1652 1661	H. pylori
#42	AnnotatorNotes T48	C0079488; Helicobacter pylori; Bacterium
T49	LIVB 251 260	H. pylori
#43	AnnotatorNotes T49	C0079488; Helicobacter pylori; Bacterium
T51	LIVB 857 866	H. pylori
#44	AnnotatorNotes T51	C0079488; Helicobacter pylori; Bacterium
T52	LIVB 1592 1601	H. pylori
#45	AnnotatorNotes T52	C0079488; Helicobacter pylori; Bacterium
A1	Assertion T11 Speculated
T47	Neg_cue 1407 1409	no
T50	CONC 1415 1426	diferencias
A2	Assertion T50 Negated
#46	AnnotatorNotes T50	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T47 Arg2:T50	
T53	Quantifier_or_Qualifier 1671 1677	triple
R2	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T53	
T54	Quantifier_or_Qualifier 310 316	triple
R3	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T54	
T55	Quantifier_or_Qualifier 644 651	triples
R4	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T55	
T56	LIVB 1376 1397	grupos de tratamiento
#47	AnnotatorNotes T56	C5205742; Treatment Group; Population Group
R5	Experiences Arg1:T56 Arg2:T30	
R6	Used_for Arg1:T3 Arg2:T2	
R7	Used_for Arg1:T4 Arg2:T2	
R8	Has_Duration_or_Interval Arg1:T4 Arg2:T43	
R9	Has_Duration_or_Interval Arg1:T3 Arg2:T43	
R10	Combined_with Arg1:T8 Arg2:T9	
R11	Combined_with Arg1:T9 Arg2:T10	
T57	Observation 401 414	bien tolerada
R12	Overlap Arg1:T7 Arg2:T57	
R13	Used_for Arg1:T8 Arg2:T7	
R15	Speculation Arg1:T44 Arg2:T11	
R16	Used_for Arg1:T8 Arg2:T39	
R17	Combined_with Arg1:T15 Arg2:T16	
R18	Combined_with Arg1:T16 Arg2:T17	
R19	Used_for Arg1:T15 Arg2:T14	
R20	Combined_with Arg1:T18 Arg2:T19	
R21	Combined_with Arg1:T19 Arg2:T20	
R22	Used_for Arg1:T18 Arg2:T14	
R23	Before Arg1:T14 Arg2:T13	
R24	Experiences Arg1:T45 Arg2:T21	
R25	Experiences Arg1:T45 Arg2:T40	
R26	Experiences Arg1:T51 Arg2:T40	
R27	Before Arg1:T41 Arg2:T22	
R28	Experiences Arg1:T45 Arg2:T22	
R29	Experiences Arg1:T45 Arg2:T23	
R30	Has_Duration_or_Interval Arg1:T22 Arg2:T46	
R32	Before Arg1:T21 Arg2:T41	
T59	Quantifier_or_Qualifier 1028 1038	optimizada
R33	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T59	
T60	Observation 1066 1076	tolerancia
T61	Observation 1433 1443	tolerancia
R34	Used_for Arg1:T34 Arg2:T33	
R35	Used_for Arg1:T34 Arg2:T32	
R36	Causes Arg1:T52 Arg2:T35	
R40	Causes Arg1:T49 Arg2:T6	
R41	Used_for Arg1:T38 Arg2:T37	
R44	Before Arg1:T41 Arg2:T23	
R45	Has_Duration_or_Interval Arg1:T23 Arg2:T46	
#49	AnnotatorNotes T57	C5684674; patient tolerated procedure well; Finding
#50	AnnotatorNotes T60	C5684674; patient tolerated procedure well; Finding (?)
#51	AnnotatorNotes T61	C5684674; patient tolerated procedure well; Finding (?)
#48	AnnotatorNotes T53	C0205174; Triplicate; Quantitative Concept
#52	AnnotatorNotes T54	C0205174; Triplicate; Quantitative Concept
#53	AnnotatorNotes T55	C0205174; Triplicate; Quantitative Concept
#54	AnnotatorNotes T22	C0040808; Treatment Protocols; Therapeutic or Preventive Procedure 
A3	Experiencer T56 Patient
A4	Experiencer T45 Patient
